Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL4130229

VODOBATINIB
🧪 Phase II
Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
🧪 Phase II
Cc1ccc(C(=O)NNC(=O)c2c(C)cccc2Cl)cc1C#Cc1cnc2ccccc2c1

Basic Information

ChEMBL ID CHEMBL4130229
Name VODOBATINIB
Phase Phase II
Structure Type MOL
InChI Key ZQOBVMHBVWNVBG-UHFFFAOYSA-N

Known Names

K-0706 K0706 Sco-088 Vodobatinib
3
Targets
5
Activities
1
Assay Types
0
PK Parameters
5
Publications
4
Known Names
5
Indications
2
Mechanisms

Molecular Properties

453.9
MW (Da)
4.98
ALogP
3
HBA
2
HBD
71.1
PSA (Ų)
0.33
QED
0
Ro5 Violations
2
Rot. Bonds

Drug Information

Molecule Type Small molecule
Chirality Achiral
USAN Stem -tinib
USAN Year 2019

Extended Properties

Molecular Formula C27H20ClN3O2
MW 453.93
Aromatic Rings 4
Heavy Atoms 33
NP-Likeness -1.39

Mechanism of Action

Mechanism Action Type Target Direct Efficacy
Tyrosine-protein kinase ABL inhibitor INHIBITOR Tyrosine-protein kinase ABL1
Bcr/Abl fusion protein inhibitor INHIBITOR Bcr/Abl fusion protein

Indications

Dementia Parkinson Disease Leukemia, Myelogenous, Chronic, BCR-ABL Positive Leukemia, Myeloid Neurodegenerative Diseases

Activity Summary

IC50 5 meas. best 9.05

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
Bcr/Abl fusion protein
CHEMBL2096618
IC50 9.05 9.05 0.9 1
Unchecked
CHEMBL612545
IC50 6.81 6.795 154.0 2
BCR/ABL1
CHEMBL4523652
IC50 6.78 6.245 165.0 2

Activity Data Samples

Top measurements by pChEMBL value

Literature References

Data from ChEMBL 36 via Core Engine